Quick Answer
Marker Therapeutics, Inc. reported Total Assets of $19.07 million for the year ending 2025.
- Marker Therapeutics, Inc. showed a decrease of -13.4% in Total Assets from 2024 to 2025.
- This data is from Marker Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2010 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $92.0 thousand | Q1 2012: $94.8 thousand | Q3 2012: $60.7 thousand | Q4 2012: $87.4 thousand | Q1 2013: $185.3 thousand | Q3 2013: $150.0 thousand | Q4 2014: $224.4 thousand | Q1 2015: $1.54 million | Q3 2016: $9.70 million | Q1 2017: $6.11 million | Q2 2017: $10.14 million | Q3 2017: $7.70 million | Q1 2018: $2.93 million | Q2 2018: $7.89 million | Q3 2018: $4.39 million | Q1 2019: $58.99 million | Q2 2019: $55.00 million | Q3 2019: $51.40 million | Q1 2020: $42.89 million | Q2 2020: $48.52 million | Q3 2020: $48.57 million | Q1 2021: $88.36 million | Q2 2021: $80.47 million | Q3 2021: $71.94 million | Q1 2022: $54.96 million | Q2 2022: $52.32 million | Q3 2022: $41.11 million | Q1 2023: $27.94 million | Q2 2023: $21.96 million | Q3 2023: $19.49 million | Q1 2024: $14.09 million | Q2 2024: $11.68 million | Q3 2024: $10.91 million | Q1 2025: $16.99 million | Q2 2025: $14.77 million | Q3 2025: $21.73 million.
- Over the full 14 years of available data (2010 to 2025), Marker Therapeutics, Inc.'s Total Assets has grown by 16,279.4%.
- Historical annual values: Fiscal year 2025: $19.07 million | Fiscal year 2024: $22.02 million | Fiscal year 2023: $17.13 million | Fiscal year 2022: $34.42 million | Fiscal year 2021: $68.14 million | Fiscal year 2020: $45.61 million | Fiscal year 2019: $46.36 million | Fiscal year 2018: $62.14 million | Fiscal year 2017: $5.18 million | Fiscal year 2016: $7.92 million | Fiscal year 2015: $6.65 million | Fiscal year 2012: $104.2 thousand | Fiscal year 2011: $307.9 thousand | Fiscal year 2010: $116.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: